VC
Australia
New Fund 2024

Brandon Capital Partners

Check Size
€1M – €10M

Investment Focus

Investment Stages

Geographic Focus

Australia
New Zealand

Investment Thesis

Australia's leading life sciences and healthcare VC with A$700M+ AUM. Manages the Medical Research Commercialisation Fund (MRCF) and has invested in 50+ companies translating research breakthroughs into clinical-stage therapeutics.

How to Pitch Brandon Capital Partners

No Stated Policy
Brandon Capital Partners hasn't published an outreach policy. A short, specific cold email is the safest default.
Source

Portfolio Highlights

Firebrick Pharma - Australian pharmaceutical company developing nasal spray treatments
Polynovo - Australian biotech developing tissue regeneration products (ASX IPO)
Adherium - Digital health company for respiratory medication adherence (ASX/NASDAQ)

Focus and check size from the firm's website. Website reachable as of Aug 2026.

Ready to Reach Brandon Capital Partners?

A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.